| Efficiency of database search for identification of mutated and modified proteins via mass spectrometry PA Pevzner, Z Mulyukov, V Dancik, CL Tang Genome research 11 (2), 290-299, 2001 | 197 | 2001 |
| Automatic pathway building in biological association networks A Yuryev, Z Mulyukov, E Kotelnikova, S Maslov, S Egorov, A Nikitin, ... BMC bioinformatics 7, 1-13, 2006 | 120 | 2006 |
| Ionization, dissociation, and level shifts of H 2+ in a strong dc or low-frequency ac field Z Mulyukov, M Pont, R Shakeshaft Physical Review A 54 (5), 4299, 1996 | 83 | 1996 |
| Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration F Grassmann, S Harsch, C Brandl, C Kiel, P Nürnberg, MR Toliat, ... JAMA ophthalmology 137 (8), 867-876, 2019 | 33 | 2019 |
| EULER-PCR: finishing experiments for repeat resolution Z Mulyukov, PA Pevzner Biocomputing 2002, 199-210, 2001 | 22 | 2001 |
| A plateau in high-order harmonic generation for a two-level atom VP Krainov, ZS Mulyukov Laser Phys 4, 544, 1994 | 18 | 1994 |
| Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis U Schmidt-Erfurth, Z Mulyukov, BS Gerendas, GS Reiter, D Lorand, ... Eye 37 (6), 1160-1169, 2023 | 16 | 2023 |
| Comparison of the efficacy of brolucizumab with natural disease progression in wet AMD using clinical data from the phase III HAWK and HARRIER trials and modelled placebo data H Agostini, Z Mulyukov, M Tsilimbaris, P Calvo, F Bucher, D Gaucher, ... Current eye research 45 (10), 1298-1301, 2020 | 16 | 2020 |
| Neovascular age‐related macular degeneration: a visual acuity model of natural disease progression and ranibizumab treatment effect Z Mulyukov, S Weber, E Pigeolet, A Clemens, T Lehr, A Racine CPT: Pharmacometrics & Systems Pharmacology 7 (10), 660-669, 2018 | 11 | 2018 |
| Breakup of H 2+ by one photon in the presence of a strong dc field Z Mulyukov, R Shakeshaft Physical Review A 63 (5), 053404, 2001 | 10 | 2001 |
| Effect of retinal thickness variability on visual outcomes and fluid persistence in neovascular age-related macular degeneration: a post hoc analysis of the HAWK and HARRIER … PU Dugel, CD Jhaveri, U Chakravarthy, CC Wykoff, RP Singh, R Hamilton, ... Retina 42 (3), 511-518, 2022 | 9 | 2022 |
| Characteristics and spatial distribution of structural features in age-related macular degeneration: a MACUSTAR Study report M Saßmannshausen, C Behning, J Weinz, L Goerdt, JH Terheyden, ... Ophthalmology Retina 7 (5), 420-430, 2023 | 8 | 2023 |
| Acceleration of electrons under the ionization of atoms by focused laser pulse radiation VP Krainov, ZS Mulyukov Laser Physics 4 (3), 509-511, 1994 | 4 | 1994 |
| A comparison of the therapeutic response between brolucizumab and aflibercept in the HAWK & HARRIER trials using deep learning-based OCT analysis U Schmidt-Erfurth, Z Mulyukov, BSS Gerendas, P Margaron, D Lorand, ... Investigative Ophthalmology & Visual Science 61 (7), 1159-1159, 2020 | 3 | 2020 |
| A Quasistationary State in a Zero-Range Potential Well Perturbed by a Superstrong Electric Field VP Krainov, ZS Mulyukov LASER PHYSICS 3 (3), 756-758, 1993 | 2 | 1993 |
| Brolucizumab 12-and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials M Singer, AM Khanani, A Wolf, R Flores, J Chhablani, A Clemens, K Gedif, ... Ophthalmologica 245 (4), 315-322, 2022 | 1 | 2022 |
| Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modelling approach Y Xiong, E Pigeolet, Z Mulyukov, P Margaron, A Racine, A Clemens Contemporary clinical trials 80, 34-39, 2019 | 1 | 2019 |
| Part I. Break Up of the Hydrogen Molecular Ion by an Electric Field. Part II. Protein Identification via Mass Spectrometry Z Mulyukov University of Southern California, 2000 | 1 | 2000 |
| Development and valuation of a preference-weighted measure in Age-Related Macular Degeneration from the Vision Impairment in Low Luminance (VILL) questionnaire–A MACUSTAR report D Rowen, J Carlton, JH Terheyden, RP Finger, N Wickramasekera, ... Value in Health, 2024 | | 2024 |
| A computer-implemented system and method for assessing a level of activity of a disease or condition in a patient's eye HS Chang, DFC Lorand, Z Mulyukov US Patent App. 17/916,980, 2023 | | 2023 |
